AEON Biopharma, Inc. (AEON) AMEX
0.71
-0.02165(-2.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
AEON Biopharma, Inc.
Address
4040 Macarthur Boulevard
Newport Beach, CA 92614
United States of America (the)
Phone
949-354-6499
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
July 24, 2023
Key Executives
| Name | Title | Pay | Year Born |
| Robert Bancroft | President, Chief Executive Officer & Director | 585,315 | 1965 |
| Alex Wilson | Chief Legal & Strategy Officer and Corporate Secretary | 725,333 | 1987 |
| Chad K. Oh | Chief Medical Officer | 741,767 | 1958 |
| John A. Bencich | Chief Financial Officer | 0 | 1977 |
| Jennifer Sy | Chief Accounting Officer | 0 | 1986 |
Description
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
